No Data
No Data
Australian Stocks With U.S. Exposure Could Be a 'Trump Trade' Bet -- Market Talk
Investors looking to bet on so-called "Trump trade" could look to overweight Australian stocks with high U.S. exposure, say Macquarie analysts in a note.
Express News | Resmed Inc : UBS Raises Target Price to $210 From $195
Do Weight Loss Drugs Pose a Threat to ResMed Shares?
ResMed Inc (ASX: RMD) shares have been under the spotlight recently after sliding from their previous highs of $33.10 apiece.
Buy Resmed Shares at 'Attractive Entry Level' Says Top Broker
ResMed Inc (ASX: RMD) shares have been on an interesting journey this year to date.
Why the ResMed Share Price Tanked in FY 2024 and What to Expect in FY 2025
The ResMed Inc (ASX: RMD) share price hit some rough patches in the financial year just past.
GLP-1 Concerns Clobbered This Healthcare Stock. Now It's Time to Buy.
ResMed makes its bank from products that battle sleep apnea. When that business seemed threatened, investors fled. Now it looks like they were too hasty. By Jacob Sonenshine ResMed is the latest
No Data
muhamad Hazairudin s : Muhammad Hazairudin Shadan
151685330 : buying the dip, can see gains in next 2 weeks into July.